Abstract
Proton therapy plans are often thought to be highly sensitive to range and setup uncertainties. This study investigated robustness of passive scattering proton therapy (PSPT) plans used for treating targets of lung cancer patients and compared the worse-case scenario plans with the nominal proton plans as well as with the corresponding IMRT plans.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date
